Reference

·

Primary source

EU-Thailand FTA Bio Annex tariff arbitrage vs China

0% vs 6.5%

As ofPost-ratification, effective late 2026 to 2027·Sources1·Primary

Effective tariff treatment for Thai PLA, succinic acid, levulinic acid, bio-PE, bio-PET into the European Union under the FTA Bio Annex signed March 2026, versus the standard 6.5 percent tariff applying to Chinese bioplastics. Structural arbitrage materially supports Thai-sourced volume capture across European brand-owner offtake.

Figure in context

Effective tariff treatment for Thai PLA, succinic acid, levulinic acid, bio-PE, bio-PET into the European Union under the FTA Bio Annex signed March 2026, versus the standard 6.5 percent tariff applying to Chinese bioplastics. Structural arbitrage materially supports Thai-sourced volume capture across European brand-owner offtake.

Effective tariff treatment for Thai PLA, succinic acid, levulinic acid, bio-PE, bio-PET into the European Union under the FTA Bio Annex signed March 2026, versus the standard 6.5 percent tariff applying to Chinese bioplastics. Structural arbitrage materially supports Thai-sourced volume capture across European brand-owner offtake.

Time scope

Post-ratification, effective late 2026 to 2027

Source basis

Primary source

Interpretation notes

What this tells you

Effective tariff treatment for Thai PLA, succinic acid, levulinic acid, bio-PE, bio-PET into the European Union under the FTA Bio Annex signed March 2026, versus the standard 6.5 percent tariff applying to Chinese bioplastics. Structural arbitrage materially supports Thai-sourced volume capture across European brand-owner offtake.

What not to do with it

Use the linked report for interpretation and keep basis differences explicit.

Related figures

Adjacent numbers that add context without drowning the value.

Report context

Thailand BCG Bio-Circular Green Economy 2027 Market Intelligence

Thailand's Bio-Circular-Green (BCG) Economy is the country's flagship national industrial strategy, positioning the kingdom as ASEAN's premier biotech, circular-economy, low-carbon production hub. The framework spans four pillars: bio-agriculture (functional food, biopesticides, bio-stimulants), bioenergy (biofuel, biogas, biomass-to-power), biochemicals (lactic, succinic, levulinic acid plus PLA bioplastics), and bioproducts (cosmeceuticals, nutraceuticals, medical-grade). The 2027 catalyst stack is unusually dense: BOI Section 8 BCG Economy bonus (additional 5-year tax holiday plus 50% local-content procurement preference), Eastern Economic Corridor of Innovation (EECi) Wangchan Valley biopharma and biorefinery cluster ramping to 80% occupancy, NSTDA BIOTEC plus Mahidol and KMITL spin-out pipeline (three IPOs targeted by 2027), Coca-Cola, Unilever, Nestle, PepsiCo signing Thailand-sourced PLA, bio-PE, bio-PET offtake reaching USD 1.4-2.2B, the MOST plus MOC plus Industry Ministry Bio-Cluster Strategic Investment Fund (USD 1.5B 2025-2030), the EU-Thailand FTA Bio Annex (signed March 2026) granting Thai PLA, biochemicals 0% tariff into the EU versus 6.5% for China, and T-VER carbon-credit stacking adding 7-12% IRR to bioenergy projects. Base case: 2027 Thai BCG framework cluster gross output reaches USD 24-36B (vs USD 11-15B in 2024), with PTTGC, CPF, Mitr Phol, IVL, ThaiBev, NSTDA BIOTEC, and EECi capturing 70%-plus share. Long-tail of BCG-aligned biotech start-ups and SME bio-processors absorbs the remainder.

Open report →

Atlas actors in this figure's reports

Profiles covered in the report that cite this number.

EU-Thailand FTA Bio Annex tariff arbitrage vs China · Insight